share_log

啓明醫療-B：委任首席財務官及繼續暫停買賣

VENUS MEDTECH-B: APPOINTMENT OF CHIEF FINANCIAL OFFICER AND CONTINUED SUSPENSION OF TRADING

香港交易所 ·  Jan 4 04:08
Summary by Moomoo AI
啟明醫療-B（股份代號：2500）宣布自2024年1月4日起，王飛先生正式出任公司首席財務官。王先生擁有超過20年的財務及戰略規劃經驗，曾於三生製藥集團及阿斯利康擔任高級財務職位。此項委任是繼馬海越先生於2023年6月2日辭任後，經過一段時間的空缺和董事會提名委員會的推薦程序後作出的決定。與此同時，啟明醫療-B的股份自2023年11月23日起在聯交所暫停買賣，將繼續暫停直至另行通知。公司股東及潛在投資者需審慎行事。
啟明醫療-B（股份代號：2500）宣布自2024年1月4日起，王飛先生正式出任公司首席財務官。王先生擁有超過20年的財務及戰略規劃經驗，曾於三生製藥集團及阿斯利康擔任高級財務職位。此項委任是繼馬海越先生於2023年6月2日辭任後，經過一段時間的空缺和董事會提名委員會的推薦程序後作出的決定。與此同時，啟明醫療-B的股份自2023年11月23日起在聯交所暫停買賣，將繼續暫停直至另行通知。公司股東及潛在投資者需審慎行事。
Kai Ming Medical -B (stock code: 2500) announced that Mr. Wang Fei has officially appointed Chief Financial Officer of the Company with effect from 4 January 2024. Mr. Wang has more than 20 years of financial and strategic planning experience and has held senior finance positions at Sanseng Pharmaceuticals Group and Aslikon. This appointment is a decision taken after Mr. Gima Hai Yue resigned on June 2, 2023, after a period of vacancy and a recommendation process by the Nomination Committee of the Board of Directors. At the same time, Kai Ming Medical-B shares have been suspended from trading on the exchange from 23 November 2023 and will continue to be suspended until further notice. Shareholders and potential investors should act with caution.
Kai Ming Medical -B (stock code: 2500) announced that Mr. Wang Fei has officially appointed Chief Financial Officer of the Company with effect from 4 January 2024. Mr. Wang has more than 20 years of financial and strategic planning experience and has held senior finance positions at Sanseng Pharmaceuticals Group and Aslikon. This appointment is a decision taken after Mr. Gima Hai Yue resigned on June 2, 2023, after a period of vacancy and a recommendation process by the Nomination Committee of the Board of Directors. At the same time, Kai Ming Medical-B shares have been suspended from trading on the exchange from 23 November 2023 and will continue to be suspended until further notice. Shareholders and potential investors should act with caution.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more